Ionic mechanisms of ischemia-related ventricular arrhythmias

Clinical Cardiology

Volumn 19, Issue 4, 1996, Pages 325-331

  Ducceschi, Valentlno ^a   Micco, Gianluca Di ^a   Sarubbi, Berardo ^a   Russo, Biancamaria ^a   Santangelo, Lucio ^a   Iacono, Aldo ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

arrhythmias; channels; ions; ischemia

Indexed keywords

ANTIARRHYTHMIC AGENT; ION CHANNEL;

CALCIUM TRANSPORT; DRUG EFFICACY; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; REVIEW;

EID: 0029830651     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960190409     Document Type: Review

References (106)

1. Vaughan Williams EM: Classification of antiarrhythmic drugs. In Cartlwc Arrhythmias (Eds. Sandoe E, Rensted-Jense F, Olsen K). Sodertalje, Sweden: Astra, 1970:449-472
2. Singh BN, Vaughan Williams EM: A fourth class of antidysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials and on other features of cardiac function. Ctirtliovasc Res 1972;6:109-119
3. Vaughan Williams EM: Classifying antiarrhythmic actions: By facts or speculation. J Clin Phannacol 1992;32:964-977
4. Vaughan Williams EM: Significance of classifying antiarrhythmic actions since the Cardiac Arrhythmia Suppression Trial. J Clin Phannacol 1991 ;31:123-135
5. Camm AJ, Ward DE: Antiarrhythmic drugs. Hospital Update 1981;11:1149-1154
6. Touboul P, Altaian G, Gressade A, Michelon G, Châtelain MT, Delahave JP: Affets electrophysiologiques des agents antiarrhythmiques chez l'homme. Tentative de classification. Arch Mal Co(H979;72:72-78
7. Milne JR, Hellestrand KJ, Bexton RS, Bumett PJ, Debbas NM Camm AJ: Class I antiarrhythmic drugs-a subdivision based on surface electrocardiographic effect. Characteristic electrocardiographic differences when assessed by atrial and ventricular pacing. Ear Heart J 1984;5:99-107
8. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology: The Sicilian Gambit: A new approach to the classification of antiarrhythmic drugs based on their action on anhythmogenic mechanisms. Circulation 1991;84: 1831-1851;£m-/fairr./1991;l2:1112-1131
9. Silverman HS, Stern MD: Ionic basis of ischaemic cardiac injury: Insights from cellular studies. Cardiovasc Res 1994;28:581-597
10. .Coronel L, Wilms-Schopman FJG, Opthof T: Reperfusion arrhythmias in isolated perfused pig hearts: Inhomogeneities in extracellular potassium, ST and TQ potentials and transmembrane action potentials. Circulation 1992;71:1131-1142
11. Johnson TA, Engle CL, Boyd LM: Magnitude and time course of extracellular potassium inhomogeneities during acute ischemia in pigs: Effect of verapamil. Circulation 1991;83:622-634
12. Harris AS, Bisteni A, Rüssel RA: Excitatory factors in ventricular tachycardia resulting from myocardial ischemia: Potassium a major excitant. Science 1954; 119:200-203
13. Harris AS: Potassium and experimental coronary occlusion. Am Heart J 1966;71:797-802
14. Pelleg A, Mitamura H, Price R: Extracellular potassium ion dynamics and ventricular arrhythmias in the canine heart. JAin Coll CW/o/1989;13:941-950
15. Janse MJ, Wit AS: Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 1989;69:1049-1169
16. Gilmour RF, Zipes DP: Abnormal automaticity and related phenomena. In The Heart and Cardiovascular System (Eds. Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE). New York: Raven Press, 1986:1239-1257
17. Vanheel B, de Hemptinne A: Influence of K ATP channel on modulation on net potassium efflux from ischaemic mammalian cardiac tissue. Cardiovasc Res 1992;26:1030-1039
18. VankateshN,LampST,WeissJM: Sulfonylureas, ATP sensitive potassium channels and cellular K loss during hypoxia, ischemia and metabolic inhibition in mammalian ventricle. Circ Res 1991 ; 69:623-637
19. Kantor PF, Coetzee WA, Carmeliet EE: Dennis SC, Opie LH. Reduction of ischémie K loss and arrhythmias in rat hearts: Effect ofglibenclamide.asulfonylurea. Circ Res 1990;66:478-485
20. Furukawa T, Kimura S, Furukawa N, Bassett AL, Myerburg RJ: Role of cardiac ATP-reguIated potassium channels in differential responses of endocardial and epicardial cells to ischemia. Circ Res 1991;68:1693-1702
21. Billman GE: Role of ATP sensitive potassium channel in extracellular potassium accumulation and cardiac arrhythmias during myocardial ischemia. Cardiovasc Res 1994;28:762-769
22. Ettinger PO, Regan TJ, Oldewurtel HA, Khan MI: Ventricular conduction delay and arrhythmias during regional hyperkalemia in the dog. QVr/to 1973;33:521-531
23. Tweedie D, Henderson G, Kane K: Glibenclamide but not class III drugs prevents ischaemic shortening of refractory period in guinea-pighearts.£rJf/wn(wco/1993;240:251-258
24. Cacciapuoti F, Spieza R, Bianchi M, LamaD, D'Avino M: Effectiveness of glibenclamide on myocardial ischémie ventricular arrhythmias in non-insulin dependent diabetes mellitus. Am J Cardiol 1991;67:843-847
25. Tbsaki A, Hellegouarch A: Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts. J Am Coll Cardiol 1994;23:487-496
26. Di Diego JM, Antzelevitch C: Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissue: Does activation of ATP-regulated potassium current promote phase 2 reentry? Circulation 1993;88:1177-1189
27. Black SC, Lucchesi BR: Potassium channel openers are likely to be proarrhythmic in the diseased human heart. Cardiovasc Res 1994:28:923-924
28. Steenbergen C, Murphy E, Levy LA: Increase in cytosolic free magnesium during ischemia: Possible mechanisms. Circulation 1989;80:II-19
29. Rasmussen HS, Aurup P, Hojberg S, Jensen EK, McNair P: Magnesium and acute myocardial infarction. Transient hypomagnesemia not induced by renal magnesium loss in patients with acute myocardial infarction. Arch Intern Med 1986; 146:872-874
30. Flink EB, Brick JE, Shane SR: Alterations of long-chain free fatty acids and magnesium concentrations in acute myocardial infarction. A rch Intern Med \981 ; 141:441 -443
31. Keller PK, Aronson RS: The role of magnesium in cardiac arrhythmias. Prog Cardiovasc Dis 1990;32:433-448
32. Ramee SR, White CJ, Svinarich JT, Watson TD, Fox RF: Torsade de pointes and magnesium deficiency. Am Mean J 1985;109: 164-167
33. Sjogren A, Edvinsson L, Fallgren B: Magnesium deficiency in coronary artery disease and cardiac arrhythmias. J Intern Med 1989;226:213-222
34. White RE, Hartzell HC: Magnesium ions in cardiac function. Regulator of ion channels and second messengers. Biochem Farmacol 1989;38:859-867
35. Woods KL, Fletcher S, Roffe C, Haider Y: Intravenous magnesium sulphate in suspected acute myocardial infarction: Results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1992;339:1553-1558
36. Shechter M, Hod H, Chouraqui P, Kaplinsky E, Rabinowitz B: Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol 1995; 75:321-323
37. Sudakov KV, Yumatov EA, Ul'yaninsky LS: Systemic mechanisms of emotional stress. In Stress Development Mechanisms (Eds. Furduj FI, Khaidarliu SK, Shtirtu EL, Nadvodnyuk AI, Mamalyga LM). Shtiintza, Kishinev 1987:52
38. Meerson FZ, Arkhipenko YV, Rozhitskaya II, Kagan VE: Damage to the sarcoplasmic reticulum Ca-transporting system in emotional pain stress. ByullEksperBiolMedl9;9l:405-406
39. Meerson FZ: Stress-induced arrhythmic disease of the heartParti. Clin Cardiol 1994; 17:362-371
40. Meerson FZ: Adaptive Pwtection of the Heart: Protecting against Stress and Ischémie Damage. Boca Raton: CRC Press, 1991
41. Verrier RL, Lown B: Sympathetic-parasympathetic interactions and ventricular electrical stability. In Neural Mechanisms in Cardiac Arrhythmias (Eds. Schwartz FT, Brown HM, Mallian A, Zanchetti A). New York: Raven Press, 1985:75
42. Priori SG, Napolitano C, Schwartz PJ: Cardiac receptor activation and arrhythmogenesis. Eur Heart J1993; 14(suppl E): 20-26
43. Priori SG, Corr PB: Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. Am J Physiol 1990;258:H 1796
44. Priori SG, Mantica M, Schwartz PJ: Delayed afterdepolarizations elicited in vivo by left stellate ganglion stimulation. Circulation 1988;78:178-185
45. Carlsson S: Mechanism of local noradrenaline release in acute niyocardial ischemia. Acta Physiol Scand(suppl 559) 1987; 129: 7-85
46. Saman S, Coetzee WA, Opie LH: Inhibition by simulated ischemia or hypoxia of delayed afterdepolarizations provoked by cyclic AMP: Significance for ischémie and reperfusion arrhythmias. JA/o/Ce//Cörcftol 1988:20:91-95
47. Wiecha J, Hombach V: Cellular electrophysiological properties in myocardial infarction. Ear Heart J1993; 14(suppl E):9-19
48. Coetzee W, Biermans G, Callewaert G, Vereecke J, Opie LH, Carmeliet E: The effect of inhibition of mitochondria! energy metabolism on the transient inward current of isolated guinea-pig ventricular myocytes. J Mol Cell Cardiol \988;20:181 -185
49. Friedman PL, Stewart JR, Fenoglio JJ Jr, Wit AL: Surviving of subendocardial Purkinje fibers after ex tensive myocardial infarction in dogs: In vivo and in vitro correlations. Circ Res 1973;33: 597-611
50. Sugi K, Karaguezian HS, Fishbein MC, McCullen A, Sato Y, Ganz W: Spontaneous ventricular tachycardia associated with isolated right ventricular infarction, one day after right coronary artery occlusion in the dog: Studies on the site of origin and mechanism. Am HeartJ 1985; 109:232-243
51. Spear JF, Michelson EL, Spielman SR, Moore EN: The origin of ventricular arrhythmias 24 hours following experimental anterior septal coronary occlusion. Circulation 1977;55:844-852
52. Lazzara R, El-Sherif N, Scherlag BJ: Electrophysiological properties of canine Purkinje cells in one day after myocardial infarction. Circ Res 1973;33:722-734
53. Bril A, Man RYK: The role of potassium and sodium-calcium exchange currents in the action potential duration of normal Purkinje fibres and Purkinje fibres surviving infarction. Cardiovasc Res 1989;23:41(M16
54. Friedman PL, Stewart JR, Wit AL: Spontaneous and induced cardiac arrhythmias in subendocardial Purkinje fibers surviving ex tensive myocardial infarctions in dogs. Circ Res 1973;33:612-626
55. Ursell PC, Gardner PI, Albala A, Fenoglio JJ Jr, Wit AL: Structural and electrophysiological features in the epicardial border zone of canine myocardial infarcts during healing. Circ Res 1985:56:436-451
56. Argentier! TM, Frame LH, Colatsky PJ: Electrical properties of canine subendocardial fibers surviving in 1 -day-old experimental myocardial infarction. CircRes 1990;66:123-134
57. El-Sherif N, Mehra R, Gough WB: Ventricular activation patterns of spontaneous and induced ventricular rhythms in canine oneday-old myocardial infarction: Evidence for focal and reentrant mechanisms. CircRes 1982;51:152-166
58. El-Sherif N, Gough WB, Zeiler RH: Triggered ventricular arrhythmias in one day old myocardial infarction in the dog. Circ /to 1983:52:566-579
59. Kass RS, Tsien RS: Fluctuation in membrane current driven in intracellular calcium in cardiac Purkinje fibres. BiophysJ 1982;38: 259-269
60. Kass RS, Tsien RW, Weingart R: Ionic basis of transient inward current induced by strophanthidin in cardiac Purkinje fibres. J Physiol \9S7;281:209-226
61. Berlin JT,Cannell MB, Lederer WJ: Cellular origins of the transient inward current in cardiac myocytes. Role of fluctuations and wave of elevated intracellular calcium. Circ Res 1989;65:115-126
62. Lipp P, Pott L: Transient inward current in guinea-pig atrial myocytes reflects a change of sodium-calcium exchange current. J Physiol 1988:397:601-630
63. Fabiato A, Fabiato F: Contractions induced by a calcium-induced release of calcium from the sarcoplasmic reticulum of skinned cardiac cells. J Physiol 1975:249:469-495
64. Orchard CH, Eisner DA, Allen DG: Oscillation of intracellular calcium in mammalian cardiac muscle. Nature 1983:34:735-738
65. Vos MA, Gorgels APM, Drenth JPH, Leunissen JD, Wellens HJ: Termination of ouabain-induced ventricular tachycardia by flunarizine in conscious dogs. EiirJPhannacol 1989;165:139-145
66. January CT, Riddle JM, Salata JJ: A model for early afterdepolarizations: Induction with the Ca channel asonist Bay K 8644. Cire fosl988;62:563-571
67. Hirano Y, Moscucci A, January CT: Direct measurement of L-type Ca-window current in heart cells. Circ Res 1992;445-455
68. Ming Z, Nordin C, Aronson RS: Role of L-type Ca channel window current in generating current-induced early afterdepolarizations. J Cardiovasc Electrophysiol 1994;5:323-334
69. Nordin C: Computer model of transmembrane current and intracellular cation concentration in the guinea pig ventricular myocyte. Am J Physiol 1993;265 (Heart Circ Physiol 34): H2117-H2136
70. Quantz NA, Nattel S: The ionic mechanism for quinidine-induced early afterdepolarizations. Circulation 1986;74:SII-420
71. Roden DM: Early after-depolarizations and torsade de pointes: Implications for the control of cardiac arrhythmias by prolonging repolarization. Eur Heart J 1993;14(suppl H):56-61
72. Wilde AAM, Janse MI: Electrophysiological effects of ATP sensitive potassium channel modulation: Implications for arrhythmogenesis. Cardiovasc Res 1994;28:16-24
73. Fish FA, Prakash C, Roden DM: Suppression of repolarization-related arrhythmias in vitro and in vivo by low-dose potassium channel activator. Circulation 199Q;82:\362-1369
74. Carlsson L, Abrahamsson C, Drews L, Düker G: Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed polarization. Circulation 1992;85:1491-1500
75. Carmeliet E: Mechanisms and control of polarization. Eur Heart J 1993;14(suppl H):3-13
76. Kaseda S, Gilmour RF, Zipes DP: Depressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyridine in canine cardiac Purkinje fibers. Am Heart J1989; 118:458
77. Bailie DS, Inoue H, Kaseda S, Ben-David J, Zipes DP: Magnesium suppression of early afterdepolarization and ventricular tachyarrhythmias induced by cesium in dogs. Circulation 1988;77:1395-1402
78. Davidenko JM, Cohen L, Goodrow R, Antzelevitch C: Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium and magnesium. Circulation 1989;79:674-686
79. Fazekas T, Scherlag BJ, Vos M, Wellens HJ, Lazzara R: Magnesium and the heart: Antiarrhythmic therapy with magnesium. Clin Cardiol 1993:16:768-774
80. Zipes DP, Miles WM, Klein LS: Mechanisms of cardiac arrhythmias in patients. In Catheter Ablation of Arrhythmias (Ed. Zipes DP). Armonk, New York (U.S.A.):Futura Publishing Company, 1994:1-60
81. Kerr MJ, Wilson R, Shanks RG: Suppression of ventricular arrhythmias after coronary artery ligation by pinacidil, a vasodilator drug. J Cardiovasc Phannacol 1985;7:875-883
82. Imanishi S, Arita M, Aomine M, Kiyosue T: Antiarrhythmic effects of nicorandil on canine cardiac Purkinje fibers. J Cardiovasc Phannacol 1984;6:772-779
83. Spinelli W, Sorota S, Siegal M: Antiarrhythmic actions of the ATP-regulated K current activated by pinacidil. Circ Res 1991 ;68: 1127-1137
84. Spear JP, Horowitz LN, Hodess AB, MacVaugh H, Moore EN: Cellular electrophysiology of human myocardial infarction. 1. Abnormalities of cellular activation. Circulation 1979;59:247256
85. De Bakker JMT, Coronel R, Tasseron S, Wilde AA, Opthof T, Janse MJ, van Capelle FJ, Becker AE, Jambroes G: Ventricular tachycardia in the infarcted, Langendorff-perfused human heart: Role of the arrangement of surviving cardiac fibers. J Am Coll Cardiol 1990;15:r594-1607
86. Ursell PC, Gardner PI, Albala A, Fenoglio JJ Jr, Wit AL: Structural and electrophysiological changes in the epicardial bor-der zone of myocardial infarct during healing. CircRes 1985;56: 436-452
87. Gardner PI, Ursell PC, Fenoglio JJ Jr, Wit AL: Electrophysiological and anatomical basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation 1985;72:596-611
88. MisierARR, OpthofT, van Hemel NM, Venneulen JT, de Bakker JM, Defauw JJ, van Capelle FJ, Janse MJ: Dispersion of refractoriness in noninfarcted myocardium of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction. Circulation 1995;91:2566-2572
89. Zareba W, Moss AJ, le Cessie S: Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. AmJCardiol 1994;74:550-553
90. Walter T, Griebl G, Neugebauer A: QT dispersion and QT dynamics in patients with coronary artery disease with and without ventricular tachycardia (abstr). PA CE 1995; 18(Part II): 1125
91. Glancy JM, Garratt CJ, Woods KL, de Bono DP: QT dispersion and mortality after myocardial infarction. Lancet 1995;345: 945-948
92. Leiten J, Basta M, Dobson A: QT dispersion does not predict early ventricular fibrillation after acute myocardial infarction. PACE 1995;18(PartI):45-48
93. Janse MJ: Classification of antiarrhythmic drugs in relation to mechanisms of arrhythmias. In Cardiac Pacing and Electrophysiology. A Bridge to the 21st Century (Eds. Aubert AE, Ector H, Stroobandt R). Dordrecht, the Netherlands: Kluwer Academic Publishers, 1994:23-30
94. Banai S, Tzivoni D: Drug therapy for torsade de pointes. J Cardiovase Elect wphysiol 1993 ;4:206-210
95. Tzivoni D, Banai S, Scuger C, Benhorin J, Keren A, Gottlieb S, Stern S: Treatment of torsade de pointes with magnesium sulfate. Circulation 1988;77:392-397
96. Park JK, Lodinilo P, Rosen MR: Effects of flunarizine on impulse initiation in canine Purkinje fibers. J Cardiovasc Electropliysiol 1992;3:306-314
97. Katritsis D, Camm AJ: New class III antiarrhythmic drugs. Eur Heart J 1993;14(supplH):93-99
98. Camm AJ, Katritsis D: How to prescribe and manage antiarrhythmic drug therapy. Eur Heart J 1992;13(suppl F):44-52
99. Russell DC, Oliver MF: Ventricular refractoriness during acute myocardial ischemia and its relationship to ventricular fibrillation. Cardiovasc Res 1978;12:221-227
100. Zuanetti G, CorrPB: Selective prolongation of repolarization prevents sustained ventricular tachycardia in dogs with previous myocardial infarction. Evaluation with three-dimensional mapping. Circulation 1990;82(suppl III):IlI-64
101. Bexton RS, Camm AJ: Drugs with a class III antiarrhythmic action. Pharmacol Tlierap 1992; 17:315-335
102. Buchanan JW, Saito T, Gettes LS: The effects of antiarrhythmic drugs, stimulation frequency, and potassium-induced resting membrane potential changes on conduction velocity and dV/dt max in guinea pig myocardium.C/rc Res 1985;56:696-703
103. Nattel S: Relationship between use-dependent effects of antiarrhythmic drugs on conduction and V max in canine Purkinje fibers. J Pharmacol Exp Ther 1987;241:282-288
104. Katritsis D, Camm AJ: Antiarrhythmic drug classifications and the clinician: A gambit in the land of chaos. Clin Cardiff! 1994;17: 142-148
105. Restivo M, Tin H, Caref EB, Patel AI, Ndtepepa G, Avitable MJ, Assadi MA, Isber N, El-Sherif N: Reentrant arrhythmias in the subacute infarction period. The proarrhylhmic effect of flecainide acetate on finctional reentrant circuits. Circulation 1995;91: 1236-1246
106. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators: Preliminary report: Effect of encainide and flecainide on mortality in randomized trial of arrhythmia suppression after myocardial infarction. N EngU Meii 1989;321:406-412